Developing vaccines to protect against influenza outbreaks
Advanced Development of Universal Vaccines for Universal Influenza
This study is working on making new vaccines that can protect against different types of the flu, especially during outbreaks, so that people can have better defense against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versatope Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Lowell, UNITED STATES) |
| Project ID | NIH-11083536 on NIH RePORTER |
What this research studies
This research focuses on creating universal vaccines that can effectively combat influenza, particularly in response to outbreaks caused by emerging infectious diseases. The approach involves formulating and manufacturing vaccine components, conducting stability tests, and performing immunogenicity and efficacy assessments in animal models. The research also includes evaluating the safety and effectiveness of these vaccines in clinical settings, aiming to provide a robust defense against influenza viruses. Patients may benefit from the development of vaccines that offer broader protection against various strains of the virus.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for influenza, such as the elderly, immunocompromised individuals, and those with chronic health conditions.
Not a fit: Patients who are not at risk for influenza or who have contraindications to vaccination may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of vaccines that provide widespread protection against influenza, potentially reducing the incidence of severe illness and outbreaks.
How similar studies have performed: Other research has shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.
Where this research is happening
Lowell, UNITED STATES
- Versatope Therapeutics, INC. — Lowell, United States (Active)
Researchers
- Principal investigator: Locher, Christopher — Versatope Therapeutics, INC.
- Study coordinator: Locher, Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.